Abstract
Objective:
To explore the significance of neonatal body indices in identifying macrosomic infants, we compared the neonatal birth weight, body length, head circumference, chest circumference, neonatal body indices, Quetelet index (QI), Kaup Index (KI), head circumference to chest circumference ratio (HC/CC) and maternal fasting blood glucose (BG) for both diabetic and healthy mothers.
Study Design:
This is a retrospective study of 177 macrosomic neonates, 100 having been born to normal mothers and 77 to diabetic mothers. Multiple regression analyses were done between neonatal body indices and maternal fasting BG.
Result:
Fetal QI and KI indices of macrosomic infants of diabetic mothers were higher compared with those born to healthy mothers, whereas the HC/CC was the reverse. The multiple regression equation used to compare neonatal physical development indices to maternal fasting BG was BG=6.959+0.031QI−(4.482 × HC/CC). QI and HC/CC had linear relationships to maternal fasting BG (P<0.05). As birth weight had no direct correlation with maternal fasting BG, it was not introduced into the regression equation.
Conclusion:
Higher QI and KI along with lower HC/CC may be a predictor of macrosomia due to maternal diabetes when compared with birth weight alone.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Al-Mendalawi MD . Fetal macrosomia greater than or equal to 4000 grams. Comparing maternal and neonatal outcomes in diabetic and non-diabetic women. Saudi Med J 2009; 30: 583.
Shirima CP, Kinabo JL . Nutritional status and birth outcomes of adolescent pregnant girls in Morogoro, Coast and Dar es Salaam regions, Tanzania. Nutrition 2005; 21: 32–38.
Lin F, Wu Y . The clinical analysis on non-diabetic macrosomia. Yi Xue Yan Jiu Sheng Xue Bao 2008; 21: 60–62.
Khosla T, Lowe CR . Indices of obesity derived from body weight and height. Br J Prev Soc Med 1967; 21: 122–128.
Billewicz WZ, Kemsley WF, Thomson AM . Indices of adiposity. Br J Prev Soc Med 1962; 16: 183–188.
International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676–682.
Kale SD, Kulkarni SR, Lubree HG, Meenakumari K, Deshpande VU, Rege SS et al. Characteristics of gestational diabetic mothers and their babies in an Indian diabetes clinic. J Assoc Physicians India 2005; 53: 857–863.
Agarwal MM, Dhatt GS, Punnose J, Koster G . Gestational diabetes: dilemma caused by multiple international diagnostic criteria. Diabet Med 2005; 22: 1731–1736.
Sacks DA, Chen W . Estimating fetal weight in the management of macrosomia. Obstet Gynecol Surv 2000; 55: 229–239.
Cunningham FG (2000) Williams Obstetrics. Beijing Kexue Press: Beijing, 2000, pp 568–572.
Zhang LH, Zhang BL . Physical development analysis of fetus whose gestational age between 28–44 weeks in fifteen cities of China. Xin Sheng Er Za Zhi 1989; 4: 97.
Liu XH, Zhang BL . Analysis on neonatal body indices of newborns with different gestational age in China. Xin Sheng Er Za Zh 1998; 13: 105–107.
Hermann GM, Dallas LM, Haskell SE, Roghair RD . Neonatal macrosomia is an independent risk factor for adult metabolic syndrome. Neonatology 2010; 98: 238–244.
Legardeur H, Girard G, Mandelbrot L . Screening of gestational diabetes mellitus: a new consensus? Gynecol Obstet Fertil 2011; 39: 174–179.
Riskin-Mashiah S, Damti A, Younes G, Auslender R . First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 2010; 152: 163–167.
Black MH, Sacks DA, Xiang AH, Lawrence JM . Clinical outcomes of pregnancies complicated by mild gestational diabetes mellitus differ by combinations of abnormal oral glucose tolerance test values. Diabetes Care 2010; 33: 2524–2530.
Fadl HE, Ostlund IK, Magnuson AF, Hanson US . Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabet Med 2010; 27: 436–441.
Leach L . Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease? Microcirculation 2011; 18: 263–269.
Grissa O, Yessoufou A, Mrisak I, Hichami A, Amoussou-Guenou D, Grissa A . Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia. BMC Pregnancy Childbirth 2010; 9: 10:7.
Forbes K, Westwood M . Maternal growth factor regulation of human placental development and fetal growth. J Endocrino 2010; 207: 1–16.
Gyurkovits Z, Kálló K, Bakki J, Katona M, Bitó T, Pál A et al. Neonatal outcome of macrosomic infants: an analysis of a two-year period. Eur J Obstet Gynecol Reprod Biol 2011; 159: 289–292.
Das S, Irigoyen M, Patterson MB, Salvador A, Schutzman DL . Neonatal outcomes of macrosomic births in diabetic and non-diabetic women. Arch Dis Child Fetal Neonatal Ed 2009; 94: 419–422.
Acknowledgements
This work was supported by 2010 Educational key laboratory Project in Liaoning province (NO. LS2010164).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Song, Y., Zhang, S. & Song, W. Significance of neonatal body indices in identifying fetal macrosomia. J Perinatol 33, 103–106 (2013). https://doi.org/10.1038/jp.2012.58
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2012.58